Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for P3 Health Partners (PIII) over the last 4 years, with Q3 2025 value amounting to -$2.2 million.

  • P3 Health Partners' Other Non Operating Income fell 58539.33% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$875000.0, marking a year-over-year decrease of 16841.28%. This contributed to the annual value of $1.5 million for FY2024, which is 68514.06% up from last year.
  • Per P3 Health Partners' latest filing, its Other Non Operating Income stood at -$2.2 million for Q3 2025, which was down 58539.33% from $583000.0 recorded in Q2 2025.
  • P3 Health Partners' Other Non Operating Income's 5-year high stood at $2.6 million during Q4 2022, with a 5-year trough of -$2.2 million in Q3 2025.
  • Moreover, its 4-year median value for Other Non Operating Income was $213000.0 (2022), whereas its average is $180400.0.
  • Data for P3 Health Partners' Other Non Operating Income shows a peak YoY increase of 170000.0% (in 2023) and a maximum YoY decrease of 207941.18% (in 2023) over the last 5 years.
  • Over the past 4 years, P3 Health Partners' Other Non Operating Income (Quarter) stood at $2.6 million in 2022, then tumbled by 92.03% to $206000.0 in 2023, then surged by 86.41% to $384000.0 in 2024, then plummeted by 662.5% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, $583000.0 for Q2 2025, and $318000.0 during Q1 2025.